SCHEMBL3958863

SCHEMBL3958863

Cc1cc(Nc2nc(N)c(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 20/20 0.78
▸ INSR P06213 19/20 0.78
▸ KCNH2 Q12809 6/20 0.78
▸ NPM1 P06748 8/20 0.76
▸ CYP3A4 P08684 2/20 0.73
▸ ABL1 P00519 1/20 0.72
▸ EGFR P00533 1/20 0.72
▸ ERBB2 P04626 1/20 0.72
▸ LCK P06239 1/20 0.72
▸ RET P07949 1/20 0.72
▸ IGF1R P08069 1/20 0.72
▸ MET P08581 1/20 0.72
▸ PDGFRA P16234 1/20 0.72
▸ CDK2 P24941 1/20 0.72
▸ AKT1 P31749 1/20 0.72
▸ KDR P35968 1/20 0.72
▸ GSK3B P49841 1/20 0.72
▸ PLK1 P53350 1/20 0.72
▸ EPHB4 P54760 1/20 0.72
▸ BTK Q06187 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3960696 0.93 ALK (0.68) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL3958814 0.92 ALK (0.66) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL18457930 0.90 ALK (0.74) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL1546327 0.87 ALK (1.00) ALKINSRKCNH2NPM1ABL1
SCHEMBL1949915 0.87 ALK (0.81) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL1546090 0.87 ALK (1.00) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL1546085 0.86 ALK (1.00) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL1014561 0.86 ALK (0.75) ALKINSRKCNH2NPM1CYP3A4
SCHEMBL1545914 0.85 ALK (1.00) ALKINSRKCNH2NPM1ABL1
SCHEMBL12213956 0.85 ALK (1.00) ALKINSRKCNH2NPM1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009032703-A1 2- (HET) ARYLAMINO-6-AMINOPYRIDINE DERIVATIVES AND FUSED FORMS THEREOF AS ANAPLASTIC LYMPHOMA KINASE INHIBITORS IRM LLC (BM) 2009-03-12 — — WO claimed
WO-2009032703-A1 2- (HET) ARYLAMINO-6-AMINOPYRIDINE DERIVATIVES AND FUSED FORMS THEREOF AS ANAPLASTIC LYMPHOMA KINASE INHIBITORS IRM LLC (BM) 2009-03-12 — — WO disclosed
WO-2009032703-A1 2- (HET) ARYLAMINO-6-AMINOPYRIDINE DERIVATIVES AND FUSED FORMS THEREOF AS ANAPLASTIC LYMPHOMA KINASE INHIBITORS IRM LLC (BM) 2009-03-12 — — WO disclosed
WO-2009032694-A1 AMINO SUBSTITUTED PYRIMIDINE, PYROLLOPYRIDINE AND PYRAZOLOPYRIMIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS AND IN TREATING PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS DANA FARBER CANCER INSTITUTE (US) 2009-03-12 — — WO disclosed
Send feedback